Long-term remission of excessive liver metastases in a breast cancer patient with chronic alcohol abuse using a monotherapy with trastuzumab

Anti-Cancer Drugs

Volumn 16, Issue 2, 2005, Pages 199-200

  Eichbaum, Michael H R ^a   Schneeweiss, Andreas ^a   Bastert, Gunther ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alcohol abuse; Breast cancer; Liver metastases; Trastuzumab

Indexed keywords

ALCOHOL; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; METHOTREXATE; TRASTUZUMAB;

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CASE REPORT; DRUG INFUSION; FEMALE; HUMAN; LIVER METASTASIS; MONOTHERAPY; PRIORITY JOURNAL; SYSTEMIC THERAPY; TREATMENT OUTCOME;

ADULT; ALCOHOLISM; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; REMISSION INDUCTION;

EID: 13844256286     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200502000-00012     Document Type: Article

References (16)

1. Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Robertson JFR, et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 2003; 89:284-290.
2. Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G. Clinical course of breast cancer patients with liver metastases. J Clin Oncol 1987; 5:773-782.
3. Hoe Al, Royle GT, Taylor I. Breast liver metastases-incidence, prognosis and outcome. J R Soc Med 1991; 84:714-716.
4. Hortobagyi GN. Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer. Semin Oncol 2001; 28(6 suppl 18):43-47.
5. McKeage K, Perry CM. Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2. Drugs 2002; 62:209-243.
6. Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 2002; 20:719-726.
7. Baselga J. Clinical trials of single-agent trastuzumab (Herceptin). Semin Oncol 2000; 27(5 suppl 9):20-26.
8. Takahashi M, Inoue K, Goto R, Tamura M, Taguchi K, Takahashi H, et al. Metastatic breast cancer of HER2 scored 2+ by IHC and HER2 gene amplification assayed by FISH has a good response to single agent therapy with trastuzumab: a case report. Breast Cancer 2003; 10:170-174.
9. Rossi A, Colantuoni G, Cantore N, Panico L, DeChiara G, Ferbo U, et al. Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-week trastuzumab schedule. A clinical case. Anticancer Res 2004; 24:317-319.
10. Sawaki M, Ito Y, Tada K, Mizunuma N, Takahasi S, Horikoshi N, et al. Efficacy and safety of trastuzumab as a single agent in heavily pretreated patients with HER2/neu-overexpressing metastatic breast cancer. Tumori 2004; 90:40-43.
11. Singletary KW, Frey RS, Yan W. Effect of ethanol on proliferation and estrogen receptor-alpha expression in human breast cancer cells. Cancer Lett 2001; 165:131-137.
12. Fan S, Meng Q, Gao B, Grossmann J, Yadegari M, Goldberg ID, et al. Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res 2000; 60:5635-5639.
13. Izevbigie EB, Ekunwe SI, Jordan J, Howard CB. Ethanol modulates the growth of human breast cancer cells in vitro. Exp Biol Med 2002; 227:260-265.
14. Meng Q, Gao B, Goldberg ID, Rosen EM, Fan S. Stimulation of cell invasion and migration by alcohol in breast cancer cells. Biochem Biophys Res Commun 2000; 273:448-453.
15. Zhu Y, Lin H, Li Z, Wang M, Luo J. Modulation of expression of ribosomal protein L7a (rpL7a) by ethanol in human breast cancer cells. Breast Cancer Res Treat 2001; 69:29-38.
16. Luo J, Miller MW. Ethanol enhances erbB-mediated migration of human breast cancer cells in culture. Breast Cancer Res Treat 2000; 63:61-69.